Julieta Leone

697 total citations
36 papers, 393 citations indexed

About

Julieta Leone is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Julieta Leone has authored 36 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 16 papers in Cancer Research and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Julieta Leone's work include Breast Cancer Treatment Studies (16 papers), Advanced Breast Cancer Therapies (12 papers) and Male Breast Health Studies (12 papers). Julieta Leone is often cited by papers focused on Breast Cancer Treatment Studies (16 papers), Advanced Breast Cancer Therapies (12 papers) and Male Breast Health Studies (12 papers). Julieta Leone collaborates with scholars based in United States, Argentina and Italy. Julieta Leone's co-authors include José Pablo Leone, Carlos Vallejo, Bernardo Amadeo Leone, Ariel Osvaldo Zwenger, J. Eduardo Pérez, Sara M. Tolaney, M. Machiavelli, Alberto Romero, Nancy U. Lin and Rachel A. Freedman and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Julieta Leone

33 papers receiving 390 citations

Peers

Julieta Leone
Luis Z. Blanco United States
H Amir Tanzania
H. T. Kim United States
Anthony Dragun United States
Jingbo Yi United States
U. Dafni Switzerland
Julieta Leone
Citations per year, relative to Julieta Leone Julieta Leone (= 1×) peers Inês Vasconcelos

Countries citing papers authored by Julieta Leone

Since Specialization
Citations

This map shows the geographic impact of Julieta Leone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julieta Leone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julieta Leone more than expected).

Fields of papers citing papers by Julieta Leone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julieta Leone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julieta Leone. The network helps show where Julieta Leone may publish in the future.

Co-authorship network of co-authors of Julieta Leone

This figure shows the co-authorship network connecting the top 25 collaborators of Julieta Leone. A scholar is included among the top collaborators of Julieta Leone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julieta Leone. Julieta Leone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leone, José Pablo, Julieta Leone, Carlos Vallejo, et al.. (2025). Factors Associated With Short- and Long-Term Survival in Metastatic HER2-Positive Breast Cancer. Clinical Breast Cancer. 25(4). 344–353.
2.
Leone, José Pablo, Julieta Leone, Faina Nakhlis, et al.. (2024). Survival outcomes and treatment patterns by tumor subtype (TS) in stage III inflammatory and non-inflammatory breast cancer (BC).. Journal of Clinical Oncology. 42(16_suppl). 607–607. 1 indexed citations
3.
Leone, José Pablo, Julieta Leone, Michael J. Hassett, et al.. (2024). Incidence, treatment patterns, and mortality for patients with breast cancer during the first year of the COVID-19 pandemic: a population-based study. Breast Cancer Research and Treatment. 210(2). 285–294. 2 indexed citations
4.
Tarantino, Paolo, Julieta Leone, Carlos Vallejo, et al.. (2024). Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer. npj Breast Cancer. 10(1). 26–26. 10 indexed citations
5.
Leone, Julieta, et al.. (2024). Survival analysis of patients with brain metastases at initial breast cancer diagnosis over the last decade. Breast Cancer Research and Treatment. 205(3). 579–587. 2 indexed citations
6.
Leone, Julieta, Michael J. Hassett, Rachel A. Freedman, et al.. (2023). Abstract PD6-08: PD6-08 Mortality risks over 20 years in men with stage I-III hormone receptor-positive breast cancer. Cancer Research. 83(5_Supplement). PD6–8. 2 indexed citations
7.
Leone, José Pablo, Noah Graham, Sara M. Tolaney, et al.. (2022). Estimating long-term mortality in women with hormone receptor-positive breast cancer: The ‘ESTIMATE’ tool. European Journal of Cancer. 173. 20–29. 4 indexed citations
8.
Leone, José Pablo, Michael J. Hassett, Julieta Leone, et al.. (2022). Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer. Cancer. 128(21). 3796–3803. 8 indexed citations
9.
Leone, José Pablo, Rachel A. Freedman, Julieta Leone, et al.. (2022). Survival in male breast cancer over the past 3 decades. JNCI Journal of the National Cancer Institute. 115(4). 421–428. 7 indexed citations
10.
Leone, José Pablo, Bernardo Amadeo Leone, Nabihah Tayob, et al.. (2021). Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry. Breast Cancer Research and Treatment. 187(3). 843–852. 9 indexed citations
11.
Leone, José Pablo, Carlos Vallejo, Michael J. Hassett, et al.. (2021). Factors associated with late risks of breast cancer-specific mortality in the SEER registry. Breast Cancer Research and Treatment. 189(1). 203–212. 16 indexed citations
12.
Leone, Julieta, Rachel A. Freedman, Nancy U. Lin, et al.. (2021). Tumor subtypes and survival in male breast cancer. Breast Cancer Research and Treatment. 188(3). 695–702. 22 indexed citations
13.
Leone, José Pablo, Carlos Vallejo, Michael J. Hassett, et al.. (2021). Correction to: Factors associated with late risks of breast cancer‑specific mortality in the SEER registry. Breast Cancer Research and Treatment. 189(1). 305–305. 2 indexed citations
14.
Leone, José Pablo, Bernardo Amadeo Leone, Ariel Osvaldo Zwenger, et al.. (2021). The prognostic significance of metastatic pattern in stage IV male breast cancer at initial diagnosis: a population-based study. Breast Cancer Research and Treatment. 187(1). 237–244. 6 indexed citations
15.
Leone, José Pablo, Julieta Leone, Ariel Osvaldo Zwenger, Carlos Vallejo, & Bernardo Amadeo Leone. (2019). Prognostic Significance of Tumor Subtypes in Women With Breast Cancer According to Stage. American Journal of Clinical Oncology. 42(7). 588–595. 19 indexed citations
16.
Leone, José Pablo, et al.. (2016). Locoregional treatment and overall survival of men with T1a,b,cN0M0 breast cancer: A population-based study. European Journal of Cancer. 71. 7–14. 32 indexed citations
17.
Leone, José Pablo, Bernardo Amadeo Leone, & Julieta Leone. (2016). Adjuvant systemic therapy in older women with breast cancer. Breast Cancer Targets and Therapy. Volume 8. 141–147. 8 indexed citations
18.
Leone, Bernardo Amadeo, Carlos Vallejo, Alberto Romero, et al.. (2016). Prognostic impact of metastatic pattern in stage IV breast cancer at initial diagnosis. Breast Cancer Research and Treatment. 161(3). 537–548. 67 indexed citations
19.
Leone, José Pablo, Ariel Osvaldo Zwenger, Julieta Leone, et al.. (2016). Prognostic factors in male breast cancer: a population-based study. Breast Cancer Research and Treatment. 156(3). 539–548. 38 indexed citations
20.
Leone, José Pablo, et al.. (2015). Prognostic significance of tumor subtypes in male breast cancer: a population-based study. Breast Cancer Research and Treatment. 152(3). 601–609. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026